10% USG masks 5% YoY revenue decline; PAT contracted amid commodity headwinds

Reported YoY revenue growth only 5%; USG/organic is 10% but actual turnover growth lags significantly

Margin within guidance; but PAT after exceptional items declined 2% YoY (reported ₹2,680 Cr down from ₹2,732 Cr prior year)

Not disclosed at segment level; management declined to quantify. Soap segment volumes down despite premium mix shift; cannot corroborate

Volume growth only 5% YoY; QoQ growth 6.1%, showing deceleration. Growth trajectory weakened from 3% H1 FY26 to 5% organic

Q4 FY26 call: 'well equipped to navigate volatility.' Q1 FY27 now: 'continue to monitor monsoons, geopolitics.' More cautious framing despite similar macro backdrop.

YoY growth 5% Q1 vs 6% Q4; USG 10% claimed but actual turnover growth is half. Volume contribution modest, pricing-led.

Reported PAT -3.2% YoY to ₹2,680 Cr (vs prior ₹2,732 Cr). Adjusted PAT +11% only after removing ₹330 Cr one-off tax benefit from base.

Personal Care USG 4%, driven by palm oil price hikes, not volume. Soaps volumes declining; premiumization (Dove/Pears +DD) insufficient to offset category headwinds.

No change, same positioning. We remain confident navigating volatility via portfolio, procurement, supply chain. Cautioning only on macro scenario.

Palm oil inflation 2 years continuous. Focus on premiumization — Dove, Pears growing double-digit. Bodywash expanding. Market share: don't disclose by segment but leading premium. Volumes to grow forward.

Won't guide by quarter. Full year FY27 ahead of FY26 retained. Consumption strong, no inflation-led FMCG demand impact observed.

Won't comment on gross margin in isolation. EBITDA guided 22.5–23.5%; P&L leverage across all lines allows us to deliver within range even with high inflation pass-through.

Must factor ROI and AI-enabled efficiency. Mix of channel and media savings offset. Look at competitive GRP/SOV — both up. Highest A&P in 11 quarters absolute.

Mass growth not behind at org level. Both competitive. Premium grows faster market-wide — we're winning at each end. Must stay competitive at mass scale.

Both robust and strong. Recent quarters show step-up in rural. Stable demand both channels.

Yes, trajectory perspective — moderation in tea volumes and soaps explains delta.

Agriculture 15% GDP; difficult vs good year = 50–60 bps GDP impact. Portfolio spread across categories insulates us. MSP up 5–6% provides rural income cushion. Monsoon deficit now 15% (was larger); <20% = no meaningful impact.

Growth non-linear in small nascent categories. Keep driving innovation curve. Extremely bullish long-term wellness opportunity.

FY27 > FY26 guidance held. Progress driven by sharp resource allocation to 'power moves' (low-penetration, high-growth segments), market development leadership, execution on distribution/assortment, portfolio towards higher-velocity areas.

Portfolio expansion: extend existing brands (Horlicks protein, Vaseline moisturization), bring Unilever brands, acquire bolt-ons (Minimalist, OZiva). Barriers to entry low but scale barriers high — Minimalist proof post-acquisition.

Soaps segmented by pop strata; different trends rural vs metros. Focus: sequentially drive volumes, premiumize via Dove/Pears, drive Bodywash, convert market to liquid.

Both. Mass doing better sequentially, premium accelerating. Three premium brands (Simple, Vaseline, Pond's) all double-digit. Online Channels of Future double-digit. Deseasonalization, democratization of sunscreen key moves.

Difficult to quantify. Playbook: pass even half inflation, maintain margins via P&L flex. Feasible in $75–100/barrel range. $140–160 = different story.

Huge opportunity to segment consumers, create channel-specific portfolio/packs. Allows subsegmentation, upsizing not previously possible. Route-to-market segmentation.

Very low-penetration segments; we're leading market development. Competition natural; we're well-placed developing & growing market, right portfolio/price for evolution.

Healthy balance long/short-term spends. ROI modelling (long & short) informs allocation per brand. Channel + media efficiency gains via proprietary ROI knowledge.

Hand wash vs bathing very different consumptions; small subsection. Huge opportunity: convert bathing (bars) to liquids (bodywash). Lead Bodywash market; sampling & education key.

Crude volatile, calibrated approach as done Q1. Remain confident Home Care portfolio. Calibrate price/savings/procurement to navigate competitively.

Early read shows inflationary trend. Will assess full season & buying season, then decide pricing based on commodity outlook.

Reaffirmed from FY'26 calls. Risk-adjusted; assumes macro headwinds & commodity volatility embedded. No quantified growth rate provided.

Q1 delivered 23%; within range via P&L leverage (savings, disciplined spend, procurement benefits offsetting ~50% inflation pass-through to consumers).

Liquids Lab, Fragrance House, AI centers, quick-commerce, omni-channel infrastructure cited. Scale/timeline vague.

Crude & palm oil elevated. Passing only ~5% inflation vs ~10% cost increase. Further pricing may trigger volume loss esp. mass (soaps, personal care already showing pressure). Niranjan: feasible at $75–100/bbl, constrained above.

Reported volume growth only 5% YoY; Q4 was 6%. Soaps volumes declining despite premiumization narrative. Tea volumes low-single digit. OZiva growth faltered. If momentum continues eroding, FY27 growth target at risk.

P&L leverage (savings, media efficiency, disciplined capex) is finite. If crude stays >$100/bbl or palm oil remains elevated, further cost cuts risk capex/innovation investment or volume loss from insufficient pricing.

Analysts (Percy Panthaki, Siddharth Negandhi) pressed on market share loss in soaps, hand wash, powder liquids at mass end. Management won't disclose segment-level share. Implied risk: premiumization strategy leaving mass undefended.

OZiva grew 80% in FY26 full year; Q1 now soft. Management vague on drivers of deceleration. Minimalist accelerating but integration dependency. If high-growth bets underperform, portfolio premiumization thesis weakens.

Call cites 'increasingly uncertain global environment.' Monsoon deficit currently 15% (manageable per Niranjan) but >20% could impact agricultural GDP 50–60 bps. El Niño, geopolitical tensions, currency volatility all unquantified.